ACHV
Price
$2.68
Change
-$0.02 (-0.74%)
Updated
Jul 25 closing price
Capitalization
133.16M
12 days until earnings call
SIGY
Price
$2.80
Change
+$0.05 (+1.82%)
Updated
Jul 11 closing price
Capitalization
4.5M
Interact to see
Advertisement

ACHV vs SIGY

Header iconACHV vs SIGY Comparison
Open Charts ACHV vs SIGYBanner chart's image
Achieve Life Sciences
Price$2.68
Change-$0.02 (-0.74%)
Volume$655.25K
Capitalization133.16M
Sigyn Therapeutics
Price$2.80
Change+$0.05 (+1.82%)
Volume$227
Capitalization4.5M
ACHV vs SIGY Comparison Chart in %
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHV vs. SIGY commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and SIGY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (ACHV: $2.68 vs. SIGY: $2.80)
Brand notoriety: ACHV and SIGY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 60% vs. SIGY: 18%
Market capitalization -- ACHV: $133.16M vs. SIGY: $4.5M
ACHV [@Biotechnology] is valued at $133.16M. SIGY’s [@Biotechnology] market capitalization is $4.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileSIGY’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • SIGY’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACHV and SIGY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 5 TA indicator(s) are bullish while SIGY’s TA Score has 0 bullish TA indicator(s).

  • ACHV’s TA Score: 5 bullish, 5 bearish.
  • SIGY’s TA Score: 0 bullish, 1 bearish.
According to our system of comparison, ACHV is a better buy in the short-term than SIGY.

Price Growth

ACHV (@Biotechnology) experienced а 0.00% price change this week, while SIGY (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ACHV is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHV($133M) has a higher market cap than SIGY($4.5M). SIGY YTD gains are higher at: -11.111 vs. ACHV (-23.864). SIGY has higher annual earnings (EBITDA): -2.39M vs. ACHV (-44.37M). ACHV has more cash in the bank: 23.2M vs. SIGY (12.9K). SIGY has less debt than ACHV: SIGY (2.51M) vs ACHV (9.96M). ACHV (0) and SIGY (0) have equivalent revenues.
ACHVSIGYACHV / SIGY
Capitalization133M4.5M2,959%
EBITDA-44.37M-2.39M1,856%
Gain YTD-23.864-11.111215%
P/E RatioN/AN/A-
Revenue00-
Total Cash23.2M12.9K179,845%
Total Debt9.96M2.51M396%
FUNDAMENTALS RATINGS
ACHV vs SIGY: Fundamental Ratings
ACHV
SIGY
OUTLOOK RATING
1..100
5944
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
6564
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (71) in the Biotechnology industry is in the same range as SIGY (85) in the null industry. This means that ACHV’s stock grew similarly to SIGY’s over the last 12 months.

ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SIGY (100) in the null industry. This means that ACHV’s stock grew similarly to SIGY’s over the last 12 months.

ACHV's SMR Rating (99) in the Biotechnology industry is in the same range as SIGY (100) in the null industry. This means that ACHV’s stock grew similarly to SIGY’s over the last 12 months.

SIGY's Price Growth Rating (64) in the null industry is in the same range as ACHV (65) in the Biotechnology industry. This means that SIGY’s stock grew similarly to ACHV’s over the last 12 months.

SIGY's P/E Growth Rating (98) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that SIGY’s stock grew similarly to ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVSIGY
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
74%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
55%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
53%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SIGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIRYY14.991.34
+9.82%
Air China, Ltd.
AOCIF20.41N/A
N/A
Autocanada Inc
KEGX0.86N/A
N/A
Key Energy Services Inc. Del
CPXWF45.32-0.13
-0.28%
Capital Power Corp.
DMEHF0.15N/A
-1.78%
Desert Mountain Energy Corp.

SIGY and

Correlation & Price change

A.I.dvisor tells us that SIGY and OTLK have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGY and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGY
1D Price
Change %
SIGY100%
N/A
OTLK - SIGY
23%
Poorly correlated
+2.00%
ACHV - SIGY
21%
Poorly correlated
-0.74%
KALA - SIGY
21%
Poorly correlated
+15.57%
CSPHF - SIGY
8%
Poorly correlated
N/A
CPMV - SIGY
6%
Poorly correlated
+25.37%
More